You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

shr3680

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy Trial in

Recruiting
  • Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
  • SHR3680
  • Placebo
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer center
Dec 28, 2021

Hepatic Impairment, Healthy Participants Trial in GuangZhou (SHR3680)

Recruiting
  • Hepatic Impairment
  • Healthy Participants
  • SHR3680
  • GuangZhou, Guangdong, China
    Guangzhou Eighth People'S Hospital
Nov 2, 2021

Breast Cancer, Metastatic Cancer Trial in Shanghai (SHR7390, Famitinib, SHR3162)

Recruiting
  • Breast Cancer
  • Metastatic Cancer
  • Shanghai, Shanghai, China
    Cancer Hospital Affiliated to Fudan University
Jul 22, 2022

Prostate Cancer Metastatic Trial in Chengdu (SHR3680+Docetaxel, SHR3680, Docetaxel)

Unknown status
  • Prostate Cancer Metastatic
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Feb 19, 2021

Prostate Cancer, Castration-resistant Prostate Cancer Trial in Shanghai (SHR3680, SHR2554)

Terminated
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 2, 2021

Drug-drug Interaction,SHR3680 Trial in Qingdao (SHR3680, digoxin, Rosuvastatin calcium)

Unknown status
  • Drug-drug Interaction,SHR3680
  • SHR3680
  • +3 more
  • Qingdao, China
    Affiliated Hospital of Qingdao University
Nov 4, 2020

Prostate Cancer, Castration-resistant Prostate Cancer Trial in Shanghai (SHR3680, SHR3162, SHR3680(Placebo))

Active, not recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • SHR3680
  • +3 more
  • Shanghai, China
    Ye Dingwei
May 12, 2020

Hormone Refractory Prostate Cancer, Metastatic Prostate Carcinoma Trial in China (SHR3680)

Unknown status
  • Hormone Refractory Prostate Cancer
  • Metastatic Prostate Carcinoma
  • SHR3680
  • Beijing, Beijing, China
  • +11 more
May 12, 2020

Prostate Cancer, Hormone-Dependent Prostate Cancer Trial in Worldwide (SHR3680, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Hormone-Dependent Prostate Cancer
  • Burgas, Bulgaria
  • +66 more
Feb 28, 2021